IONS C Frank Bennett sells $2.1M worth of shares
Sep 05, 2025, 4:37 AM
0.00%
What does IONS do
Ionis Pharmaceuticals, headquartered in Carlsbad, California, develops drugs using antisense technology and has five marketed medicines, including SPINRAZA and QALSODY, with a pipeline focused on neurology and cardiology. The company employs 927 people and has nine medicines in Phase III development.
C Frank Bennett sold 33,909 shares of IONS on 3 September at $60.62 per share, worth a total of $2.1M. They now own 101,570 IONS shares, or a 25% holding decrease.
📡️ Health Care
Insider Trades
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.